Keyword: Biogen


Biogen Acquires Human Immunology Biosciences

23.05.2024 -

Biogen Inc. and Human Immunology Biosciences (HI-Bio), a privately-held clinical-stage biotechnology company focused on targeted therapies for patients with severe immune...


Biogen Acquires Reata Pharmaceuticals

31.07.2023 -

Biogen and Reata Pharmaceuticals announced late last week that Biogen has agreed to acquire Reata for €156.51 per share in cash, reflecting an enterprise value of...


Sangamo Reviews Options as Drugmakers Terminate Deals

22.03.2023 -

US biotech Sangamo Therapeutics is studying alternative options to advance its neurological disease programs after both Novartis and Biogen ended their respective...


Merck Serono Wins Patent Dispute With Biogen

30.09.2020 -

The US Court of Appeals for the Federal Circuit on Sept. 28 set aside a decision of the US district court of New Jersey in Newark, reversing the district court’s earlier...


Biogen and Vir in COVID-19 Collaboration

13.03.2020 - Biogen and Vir Biotechnology, the new company of its former Biogen CEO George Scangos, have signed a letter of intent to develop and manufacture a new antibody to fight COVID-19...

Strategy & Management

Made in Switzerland – Exported Worldwide

06.12.2019 - The chemical, pharmaceutical and life sciences industries in Switzer­land — organized in the Scienceindustries trade association — account for 45% of total exports with around 70...


Fujifilm Boosts Healthcare with Biogen Plant

13.03.2019 - Japan’s Fujifilm is boosting its healthcare business with the proposed acquisition of Biogen (Denmark) Manufacturing for around $890 million in cash. The deal gives Fujifilm a...


Biogen Takes Nightstar Therapeutics for $877 Million

08.03.2019 - Biogen has agreed to acquire Nightstar Therapeutics, a clinical-stage gene therapy company based in London, UK. The US drug firm will pay Nightstar shareholders $25.50 for each...